Construction and identification of recombinant adenovirus vector carrying a N-terminal phosphorylation sites-deleted human IκBα mutant gene

ZHOU Lin-fu,ZHU Yi,ZHU Zi-lu,YIN Kai-sheng
DOI: https://doi.org/10.3321/j.issn:1000-4718.2006.09.031
2006-01-01
Abstract:AIM:To optimize the IκBα mutant(IκBαM)gene derived from human placenta tissue by deleting N-terminal phosphorylation sites of serine 32/36,and to construct and identify its replication-deficient recombinant adenovirus(AdIκBαM).METHODS:The IκBαM gene(203-1 003 bp)was acquired by positional cloning,followed by subcloning it into pShuttle and pGEM-T vectors for further PCR,double digestion,DNA sequencing and homology analysis.Subsequently,the expression unit of pShuttle-IκBαM containing CMV promoter,IκBαM cDNA and poly A signals was inserted into Ad5 vector,after which the resultant recombinant adenovirus AdIκBαM was packaged in 293 cells by cotransfection with lipofectamine.Western blotting analysis and electrophoretic mobility shift assay were utilized to detect the AdIκBαM-mediated expression of IκBαM gene in 293 cells and its suppressive effect on phorbol myristate acetate(PMA)-induced nuclear factor κB(NF-κB)activation in ECV304 cells,respectively.RESULTS:The relevant nucleotide and amino acid sequence of IκBαM gene was consistent with that of GenBank(accession number M69043).The titer of the prepared AdIκBαM was 4.0×10 12 pfu/L.Moreover,the IκBαM gene was expressed in 293 cells,and potently inhibited the PMA-induced NF-κB activation in ECV304 cells in a dose-dependent manner.CONCLUSION:AdIκBαM is a nonvel vector for both efficient transfer and expression of IκBαM gene as well as specific inhibition of NF-κB activity,providing a promising future for gene therapy of asthma.
What problem does this paper attempt to address?